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NEUROINVASIVE MYCOPLASMA PNEUMONIAE 
INFECTION WITHOUT INTRATHECAL ANTIBODY 
RESPONSE
Patrick M. Meyer Sauteur, MD,* Benedikt M. Huber, MD,† 
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Abstract: The pathogenesis of extrapulmonary Mycoplasma pneumoniae–asso-
ciated neurologic disease is unclear. We present a case of acute meningoencepha-
litis in a 15-year-old girl with central nervous system invasion of the bacterium 
but without intrathecal antibody synthesis. Our observations suggest that in this 
setting M. pneumoniae infection can be self-limiting and mild despite invasion 
of the central nervous system.
Key Words: Mycoplasma pneumoniae, meningoencephalitis, cerebrospinal 
fluid, polymerase chain reaction, intrathecal antibody synthesis
Accepted for publication June 26, 2012.
From the *Division of Infectious Diseases and Hospital Epidemiology, Univer-
sity Children’s Hospital; and †Department of Pediatrics, Triemli Hospital, 
Zurich, Switzerland. 
The authors have no funding or conflicts of interest to disclose.
Address for Correspondence: Patrick M. Meyer Sauteur, MD, Division of Infec-
tious Diseases and Hospital Epidemiology, University Children’s Hospital of 
Zurich, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland. E-mail: patrick.
meyer@kispi.uzh.ch.
Supplemental digital content is available for this article. Direct URL citations 
appear in the printed text and are provided in the HTML and PDF versions of 
this article on the journal’s Web site (www.pidj.com). 
Copyright © 2012 by Lippincott Williams & Wilkins
DOI: 10.1097/INF.0b013e318266abff
Mycoplasma pneumoniae is a cause of encephalitis in chil-dren,1 but it remains controversial because causation is diffi-
cult to prove. The paucity of reports on isolation of M. pneumoniae 
from the central nervous system (CNS) favors the hypothesis of 
an immune-mediated inflammation in most cases. We report on a 
15-year-old girl manifesting a few signs and symptoms of menin-
goencephalitis with CNS invasion of M. pneumoniae but without 
intrathecal antibody detection.
CASE REPORT
A 15-year-old girl was admitted with fever and complaining 
of neck pain, headache and diplopic images. She was completely 
oriented (Glasgow Coma Scale score 15) and had no nuchal rigid-
ity. Diplopia was the only abnormal finding on neurologic examina-
tion. Her personal and family history was unremarkable.
Prodromal symptoms had started 12 days earlier with fever 
and a nonproductive cough. On day 10, a chest radiograph showed 
a pulmonary infiltrate on the right side. Amoxicillin (50 mg/kg in 3 
doses daily) was started by the general practitioner. On day 11, she 
had morning vomiting.
At admission on day 13, a lumbar puncture revealed a 
pleocytosis (39 cells/mm3 with 95% lymphocytes) and normal 
protein and glucose values. Polymerase chain reaction (PCR) for 
M. pneumoniae in the cerebrospinal fluid (CSF) was positive, but 
negative in a pharyngeal swab (Institute for Medical & Molecular 
Diagnostics Ltd., Zurich, Switzerland; PCR method as described 
by Tjhie et al2 using specific primers for the M. pneumoniae 16S 
rDNA gene). Serum M. pneumoniae antibodies were increased by 
complement fixation test at 1:>640 (cutoff 1:<15) and by enzyme-
linked immunosorbent assay (ELISA; Virotech ELISA, M. pneu-
moniae IgM/IgG/IgA, Genzyme, Virotech GmbH, Rüsselsheim, 
Germany; cutoff for IgM/IgG/IgA antibodies: 1.5 Virotech Units, 
VU): IgM 31.7 VU, IgG 15.5 VU and IgA 40.7 VU (Fig., Supple-
mental Digital Content 1, http://links.lww.com/INF/B276). Blood 
tests showed a normal C-reactive protein and a white blood cell 
count of 11.7 × 109/L with 80% neutrophils. Blood and CSF cul-
tures were negative for conventional bacterial pathogens. Electro-
encephalography and cranial magnetic resonance imaging revealed 
no abnormality.
Azithromycin was administered orally for 5 days (30 mg/kg 
once daily). The patient improved significantly within 24 hours and 
was discharged home after 5 days on day 17. Complete recovery 
was noticed on a follow-up consultation on day 20 with persistently 
high immunoglobulin titers against M. pneumoniae in blood, but no 
more CSF pleocytosis and no M. pneumoniae detected in the CSF 
by PCR (Fig., Supplemental Digital Content 1, http://links.lww.
com/INF/B276). Intrathecal antibodies measured in the CSF (Viro-
tech ELISA) of lumbar punctures on days 13 and 20 were far below 
cutoff.
DISCUSSION
Neuroinvasive M. pneumoniae infection is rare3,4 and 
together with no intrathecal antibody response it has been reported 
only once in a child.5,6 Although M. pneumoniae is known mainly 
as a mucosal pathogen residing extracellularly on epithelial sur-
faces, it has been detected in extrapulmonary organs, suggesting 
dissemination.1,7 The way by which M. pneumoniae disseminates 
in the bloodstream to produce extrapulmonary disease is unclear. 
M. pneumoniae infection in our patient was based on detection of 
the bacterium by PCR in CSF and a strongly positive serology in 
blood (complement fixation test and ELISA).
The main laboratory sign of acute CNS disease was the 
increased CSF cell count.8 The inflammatory process leading to 
CNS disease caused by M. pneumoniae is induced by interleukin-18, 
interleukin-8 and interleukin-6, but without elevated interferon-γ 
and tumor necrosis factor-α.7,9 This suggests a distinct mechanism 
that distinguishes M. pneumoniae from other bacterial or viral CNS 
infections in which tumor necrosis factor-α, interferon-γ or both are 
highly elevated.7 The absence of an intrathecal antibody response in 
our case is also remarkable because it differs from other infectious 
CNS diseases in which the demonstration of intrathecal antibody 
production is, in most instances, specific for an ongoing infection 
of the CNS.8 Additionally, an autoimmune mechanism due to cross-
reacting M. pneumoniae antibodies seems unlikely.
Of note, our patient had a few signs and symptoms of 
meningoencephalitis and recovered without sequelae. Neverthe-
less, Mycoplasma species invading the CNS have been shown 
to cause neurologic injuries in animals and humans.4 The excel-
lent clinical course supported by the normal neuroimaging in our 
patient makes a direct damage of neural cells improbable. This 
is in agreement with the treatment regimen including azithromy-
cin that might have not contributed to the clinical improvement 
within 24 hours, because it was administered orally and appeared 
to be distributed into brain tissue but not into the CSF.4 Thus, 
resolution of neurologic signs and symptoms and clearance of 
M. pneumoniae from the CSF at least until day 20 was rather 
spontaneous.
The case presented here differs from a few reports on severe 
and life-threatening courses with neurologic sequelae.1,7 The 
degree of intrathecal antibody response in relation to the sever-
ity of disease is not known because it is rarely measured. Never-
theless, one might speculate that clinically more severe cases of 
M. pneumoniae–associated neurologic disease could be accompa-
nied by some degree of intrathecal antibody response consistent 
with immunologic sequelae. Thus, our report may influence the 
choice of diagnostic methods by adding serologic testing of CSF 
to serologic testing of blood and PCR of specimens from the throat 
and CSF, to elucidate the mechanism of M. pneumoniae neurologic 
disease.
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HYPERACUTE INFECTIOUS KERATITIS WITH 
PLESIOMONAS SHIGELLOIDES FOLLOWING 
TRAUMATIC LAMELLAR CORNEAL LACERATION
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Abstract: Plesiomonas shigelloides rarely causes extraintestinal human dis-
ease, and infection of ocular tissues is even rarer, never having been reported 
as the sole pathogen of posttraumatic ocular infection. We report the first case 
of infectious keratitis due solely to P. shigelloides following traumatic corneal 
laceration and a literature review with regard to P. shigelloides ocular disease.
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P lesiomonas shigelloides is a facultative anaerobic, Gram-neg-ative rod, recently recategorized into the Enterobacteriaceae 
family. Epidemiologically, P. shigelloides is indigenous to marine 
and brackish water, primarily in temperate climates.1 This patho-
gen can be food-borne and is associated with acute gastroenteritis. 
Shellfish ingestion and contact with contaminated fresh water have 
been implicated as infectious sources. Reports of extraintestinal 
infection include sepsis, meningoencephalitis, cellulitis and osteo-
myelitis.2,3 Four case reports exist with respect to P. shigelloides 
disease with ocular involvement. Two describe congenital endoph-
thalmitis.4,5 Two describe polymicrobial posttraumatic endophthal-
mitis and resolution-required enucleation.6,7 Here, we describe a 
case of infectious keratitis following traumatic lamellar corneal 
laceration, caused solely by P. shigelloides, for which prolonged 
antimicrobials and multiple debridements allowed preservation of 
the involved eye.
CASE REPORT
A 13-year-old otherwise healthy Caucasian girl presented to 
Children’s Mercy Hospital 1 day after sustaining a traumatic right 
eye injury, secondary to being struck by a rock. The rock’s source 
was the creek bed of a river in central Missouri. She complained 
of pain and blurred vision of the affected eye immediately after 
the injury. She later developed eyelid swelling and progressively 
decreased vision. On the morning after the injury, she was seen at 
a local emergency department, where concern for a ruptured globe 
led to referral.
Upon presentation to Children’s Mercy Hospital, right eye 
visual acuity was 20/400, with the left eye 20/20. On examination, 
both pupils were round and reactive, without afferent pupillary 
defects. Extraocular movements were intact bilaterally. A small 
abrasion with tenderness to palpation over the right maxillary bone 
was present. Gross right eye examination demonstrated mucopuru-
lent discharge in the lashes and diffuse conjunctival injection. Slit-
lamp examination revealed a triangular, opacified, flap-like corneal 
wound starting paracentrally and extending to the temporal limbus. 
Seidel testing, however, was negative for aqueous leakage. The 
anterior chamber revealed 3+ cells and flare, along with a 1 mm 
hypopyon. The lens was clear.
Within 18 hours of the original trauma, she underwent 
operative evaluation. The laceration was a nonpenetrating wound, 
with a 5 × 4 mm2 triangular flap. The area surrounding the flap 
was edematous and opaque, with fluffy white infiltration into the 
corneal stroma. The laceration was not sutured intraoperatively. 
Corneal cultures were obtained, and the patient was treated 
with hourly ophthalmic fortified tobramycin (14 mg/mL) solu-
tion and moxifloxacin 0.5% solution. Initial dilated funduscopic 
examination showed a 3-disk diameter macular hemorrhage. She 
was discharged home postoperatively and continued solely on 
topical tobramycin and moxifloxacin solutions at hourly dosing 
intervals, with scheduled daily outpatient ophthalmology clinic 
follow-up.
For 2 days after discharge, no notable corneal ulcer or 
hypopyon changes occurred, but on the third day she developed 
increased facial swelling, erythema, induration and tenderness 
extending from the right cheek infraorbitally to the right tragus. 
She complained of chills and sharp left upper quadrant abdominal 
pain, but denied fever, emesis or diarrhea. She was afebrile when 
hospitalized for concern for cellulitis and/or systemic infection. 
Blood cultures were obtained, and oral clindamycin was started. 
Ophthalmic tobramycin and moxifloxacin were continued.
Corneal cultures from her initial surgical encounter grew 
P. shigelloides. Based on antimicrobial susceptibilities for 
tobramycin (minimum inhibitory concentration [MIC] = 8 
